← Evidence library

BIB_160

NCT07049276 MSLT-3 — Multicentre Selective Lymphadenectomy Trial 3. Stage III post-positive-SLN management strategies. Melanoma Institute Australia + Royal Marsden. Builds on MSLT-II (BIB098). [Tasks: 16, 18] Tier: 1 (RCT) Grade: A (in progress) Retrieved: 2026-05-07

Evidence grade

A

Tier

1 (RCT)

Cited by tasks

16, 18

Identifiers

—

Full extracted findings & patient-implication analysis: bibliography/BIB_160/findings.md (research corpus). This page is a short context summary — not individualised medical advice.